Status:
COMPLETED
Intrathecal Nalbuphine is a Comparable Safer Alternative to Fentanyl for Intraoperative Pain Management During Uterine Exteriorization
Lead Sponsor:
Cairo University
Conditions:
Pain, Acute
Eligibility:
FEMALE
20-45 years
Phase:
NA
Brief Summary
In case of cesarean section (CS) delivery, spinal anesthesia is the best anesthetic choice. It is simple to perform with rapid onset of anesthesia and lower incidence of failed block. Spinal anesthesi...
Eligibility Criteria
Inclusion
- forty-two female patients
- ASA physical status I or II,
- age between 20 and 45 years,
- weight between 60 and 100 kg
- height between 160 and 180 cm
Exclusion
- ASA III or IV,
- patient refusal,
- hypotensive patients,
- infection at the site of injection,
- coagulopathy
- weight \<60 and \> 100 kg,
- anticoagulant medications,
- pre-existing neurological disease.
- uncooperative patients,
- cardiac disorder
- respiratory disorder
- allergy to local anesthetics.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT04689217
Start Date
January 1 2021
End Date
May 1 2021
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University hospitals
Cairo, Manial, Egypt, 12511